Indian Overseas Bank moves to reshape its capital structure

At full subscription, the ESPS would raise IOB’s public shareholding from 7.56% to approximately 8.04%—a net increase of about 0.48 percentage points. The approved issuance is for up to 10 crore fresh shares ^[1].

Using the latest shareholding structure and assuming all ESPS shares are classified as public, the calculation is:

• Current public-shareholding gap to 25% MPS: 25.00% − 7.56% = 17.44 pp
• Public holding after issuing 10 crore shares: approximately 8.04%
• Gap remaining after the ESPS: approximately 16.96 pp
• Portion of the pre-issuance gap addressed: 0.48 pp ÷ 17.44 pp = approximately 2.74%

Thus, the issuance addresses only about 2.7% of IOB’s remaining MPS shortfall, leaving roughly 17 percentage points still to be addressed. The estimate assumes full subscription, no other ownership changes, and that the employee-held shares qualify as public shareholding; the approval itself specifies an issuance of up to 10 crore shares.

The filed approval notice does not specify the ESPS issue price as a percentage or discount/premium to the prevailing market price, so the pricing formula cannot be established from the cited scheme documents. It only approves issuance of up to 10 crore fresh equity shares directly to eligible employees, subject to SEBI’s share-based employee-benefit regulations and other requirements ^[1].

The BVPS dilution impact is also not quantifiable from this filing alone. The notice does not disclose the bank’s existing number of shares, pre-issue book value/equity, final ESPS allotment, issue price, or issuance costs. The approved 10 crore shares are a maximum, not necessarily the actual allotment ^[2].

For reference, the relevant calculation would be:

• Post-issue BVPS = `(existing book equity + net ESPS proceeds) / (existing shares + ESPS shares)`
• The impact depends on the ESPS price relative to the bank’s pre-issue BVPS:
• issue price below pre-issue BVPS: BVPS dilution;
• issue price equal to pre-issue BVPS: broadly neutral;
• issue price above pre-issue BVPS: potentially accretive.

Therefore, pricing formula: not disclosed in the cited approval filing; estimated BVPS dilution: not determinable without the detailed scheme terms and pre-issue book-value/share-count data.

Verdict: IOB is still in the process of meeting the 25% MPS requirement. The latest SEBI approval validates the ESPS as a permissible compliance route, but it does not disclose a new deadline or confirm that the bank has received a further extension. At the latest validated shareholding, the Government held 92.44% and public shareholders 7.56%, implying a 17.44 percentage-point shortfall to the 25% norm.

MPS timeline

• IOB’s shareholding disclosure records a Government exemption for achieving MPS up to 1 August 2026.^[3]
• Separately, a June report stated that the latest relaxation from penal action was valid until September 2026.^[4]
• SEBI’s letter dated 19 October 2026 approved issuance of up to 10 crore fresh shares through the ESPS as a method for MPS compliance. The letter makes the approval case-specific and subject to applicable regulations; it does not specify a revised compliance deadline or an additional blanket extension.^[2]
• Accordingly, the bank has a permitted mechanism, but the cited disclosures do not establish that the MPS deadline has been reset or that compliance has been completed.

Other authorized capital-raising routes

Yes. The board approved an equity-raising programme of up to Rs 5,000 Crores, including premium, through one or more of the following:

• Qualified institutional placement, or QIP
• Follow-on public offer, or FPO
• Rights issue
• Preferential issue
• ESPS or a combination of these routes

The authorization is subject to statutory and regulatory approvals and may be executed in tranches.^[5] Shareholders subsequently approved the same broad authorization at the 7 July 2026 AGM.^[6]

Management has specifically indicated that the bank is pursuing the Rs 5,000 Crores equity raise, potentially through a QIP, but was still awaiting the remaining statutory and regulatory approvals before approaching the market; execution was expected in Q3 or Q4 FY27, depending on market conditions.^[7]

Two distinctions matter:

• The QIP is authorized but not reported as completed. The Rs 5,000 Crores is an upper limit, not a confirmed amount or issue size.
• The ESPS is described as being within the overall Rs 5,000 Crores equity-raising limit, so it should not automatically be treated as an additional Rs 5,000 Crores of capital.^[5]

The board also authorized up to Rs 1,000 Crores of Basel III-compliant Tier-II bonds, but that is debt capital and would not directly increase public shareholding for MPS purposes.^[5]